PUBBLICAZIONI GISCAD

pagina 7

· 

Medical treatment of colorectal cancer in elderly (>70 years): GISCAD experience and future perspectives

Tumori 2002; Jan- Feb 88 (1suppl.1): S109-12

Beretta GD, Ferrari VD, Barni S, Panera G, Labianca R.

· 

The value of oxaliplatin in combination with continuous infusion + bolus 5-fluorouracil and levo-folinic acid in metastatic colorectal cancer progressing after 5-fluorouracil based chemotherapy: a GISCAD cancer phase II trial

Tumori 2001; Nov-Dec 86(6) 465-9

Mosconi S, Cascinu S, Zaniboni A, Catalano V, Giordani P, Beretta GD, Martignoni G, Pancera G, Baldelli AM, Poletti P, Curti C, Labianca R.

· 

5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective; low cost chemotherapy for advanced colon cancer

Br J Cancer 2001; Apr 20, 84(8): 1023-8

Sobrero A, Guglielmi A, Cirillo M, Recaldin E, Frassinetti GL, Aschele C, Ravaioli A, Testori P, Caroti C, Gallo L, Pessi MA, Cortesi E, Turci D, Grossi F, Labianca R.

· 

A phase II of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).

Br Cancer 2001; Feb 84(4): 470-4

Cascinu S, Graziano F, Barni S, Labianca R, Comella G, Casaretti R, Frontini L, Catalano V, Baldelli AM, Catalano G.

Anno Oncol. 2000; Nov 11(11): 1413-20

· 

Schedule specific biochemical modulation of 5-fluorouracil in advanced cancer: a randomized study. GISCAD, IOR and collaborating centers.

Sobrero A, Zaniboni A, Frassineti GL, Ascelle C, Guglielmi A, Giuliani R, Ravaioli A, Lanfranco C, Caroti C, Arnoldi E, Barni S, Gallo L, Pessi Ma, Turci D, Cortesi E, Grossi F, Frontini L, Piazza E, Bruzzi P, Labianca R.

· 

A combination of a fixed dose rate infusion of gemcitabine associated to a bolus 5-fluorouracil in advanced pancreatic cancer, a report from the italian Group for the Study of Digestive Tract Cancer (GISCAD).

Ann Oncol 2002; Oct 11(10): 1309-11

Cascinu S, Frontini L, Labianca R, Catalano V, Barni S, Graiff C, Picone Gm Farinati E, Zonato S,  Pessi MA, Curti C, Catalano G.

FONDAZIONE
GISCAD

GRUPPO ITALIANO PER LO STUDIO DEI 

CARCINOMI DELL'APPARATO DIGERENTE

SEDE

Via Gattinoni, 4

20010 Vanzago (MI)

CONTATTI

Tel. 02 84968409

ufficio.operativo@giscad.it

© 2018 Fondazione GISCAD - P.IVA 05396970963